Several of these contracts have become public in the last few weeks, showing that they lack or weaken customary IP rights, lessening the government's leverage if the manufacturers engage in price gouging down the road. 4/
Pfizer's contract goes even further, explicitly stating that the government has no right to "march in" at all. It also leaves out other IP rights, arguing the U.S. gov't isn't entitled to them since this isn't an R&D deal. If the vax isn't approved, Pfizer doesn't get paid. /6
"This is not paying somebody to run down to Safeway to buy coffee for the office," @jamie_love says. "This is a really big contract. & when the dollar numbers r this big, I think people legitimately want to ask whether the government's protected their interests sufficiently." 7/
There's also a contradiction: Although the contract says government funds won't be used for research and development, it also says that Pfizer will get to keep any technology it develops as part of the agreement -- and that those inventions will become trade secrets. 8/
That could have ripple effects beyond the pandemic. "Instead of the normal quid pro quo—the government funds it but society eventually gets the benefit of the invention—the company can keep the information secret forever," says @ProfRobnFeldman. 9/
For its part, HHS says that it did its homework and negotiated "aggressively." It had a lot to balance. "The most critical factor was the need to obtain as quickly as possible sufficient doses of safe and effective vaccines against COVID-19 to save lives." 10/
You can follow @slupkin.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.